Search Results 441-450 of 14203 for soluble fibers

  1. Mayo Clinic Graduate School of Biomedical Sciences PhD Program - Immunology Track.

  2. Clinical Research and Trials.

  3. Gemfibrozil (Oral Route) Description and Brand Names - Mayo Clinic

    Gemfibrozil is used together with a proper diet to treat high cholesterol and triglyceride (fat) levels in the blood. This may help prevent the development of ...

  4. Laboratories - Mayo Clinic Research

    M · Magnetic Resonance: Stephen J. · Mathematical Neuro-Oncology: Kristin R. · Melanoma Research: Svetomir N. · Membrane Trafficking in Disease: Mark A. · Memory ...

  5. Parkinson's disease - Diagnosis and treatment - Mayo Clinic

    For example, eating foods high in fiber and drinking plenty of fluids can help prevent constipation that is common in Parkinson's disease. A balanced diet ...

  6. North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) - Mayo Clinic

    About this study. The North American Mitochondrial Disease Consortium (NAMDC)maintains a patient contact registry and tissue biorepository for patients with ...

  7. Funding - Cardiovascular Tissue Engineering Research Laboratory - Mayo Clinic Research

    Griffiths' lab has received funding from the California Institute for Regenerative Medicine, the American Heart Association, Howard Hughes Medical Institute and ...

  8. Classification of Breast Masses Using SAVE Method - Mayo Clinic

    About this study. The purpose of this research is to evaluate the efficacy of a new breast tissue assessment tool that provides new diagnostic information ...

  9. A Study to Promote Shared Decision Making of Treatment Choices in Patients who have Advanced Kidney Disease - Mayo Clinic

    The purpose of this study is to develop educational materials that will help patients and clinicians talk about treatment options for patients with advanced ...

  10. Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy - Mayo Clinic

    Exposure to monoclonal antibodies, cytokines, growth factors, soluble receptors, other recombinant products, or fusion proteins within 6 months prior to the ...